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Synopsis
CRISPR (clustered regularly interspaced short palindromic repeat) systems provide bacteria and archaea with adapt-
ive immunity to repel invasive genetic elements. Type I systems use ‘cascade’ [CRISPR-associated (Cas) complex
for antiviral defence] ribonucleoprotein complexes to target invader DNA, by base pairing CRISPR RNA (crRNA) to
protospacers. Cascade identifies PAMs (protospacer adjacent motifs) on invader DNA, triggering R-loop formation and
subsequent DNA degradation by Cas3. Cas8 is a candidate PAM recognition factor in some cascades. We analysed
Cas8 homologues from type IB CRISPR systems in archaea Haloferax volcanii (Hvo) and Methanothermobacter ther-
mautotrophicus (Mth). Cas8 was essential for CRISPR interference in Hvo and purified Mth Cas8 protein responded to
PAM sequence when binding to nucleic acids. Cas8 interacted physically with Cas5–Cas7–crRNA complex, stimulating
binding to PAM containing substrates. Mutation of conserved Cas8 amino acid residues abolished interference in vivo
and altered catalytic activity of Cas8 protein in vitro. This is experimental evidence that Cas8 is important for targeting
Cascade to invader DNA.
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INTRODUCTION
CRISPR (clustered regularly interspaced short palindromic re-
peat) systems were discovered in Streptococcus thermophilus
[1], by providing adaptive immunity to invasive genetic ele-
ments, recently reviewed in [2,3]. Immunity arises from base
pairing of host encoded CRISPR RNA (‘crRNA’) with invader
DNA/RNA, promoting nucleolytic degradation of the invader,
processes called ‘interference’. DNA sequences that are targeted
by crRNA are called ‘protospacers’ and can be identified from
an archive of previously encountered protospacers arrayed in a
CRISPR locus as ‘spacers’, separated from one another by repeat
sequences. ‘Adaptation’ or ‘spacer acquisition’ processes fur-
nish CRISPR with new spacer-repeat units requiring two highly
conserved CRISPR-associated (‘Cas’) proteins, Cas1 and Cas2.
Cas1–Cas2 adaptation may be functionally linked to interference
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(‘primed’) or not (‘naı¨ve’), in each case by mechanisms unclear,
reviewed in [3–5].
Cas proteins that catalyse interference show substantial di-
versity, with current classification into three major groups, types I,
II and III [6–8], characterized by distinct effector complexes that
manoeuvre crRNA to base pair with target DNA or RNA. Type I,
II and IIIA systems target DNA catalysed by respectively, ‘Cas-
cade’ (Cas complex for antiviral defence) [9,10], Cas9 [11,12] or
CSM complex [13,14]. In contrast, CMR complexes target RNA
in type IIIB CRISPR systems [15–17].
Cascades catalyse interference in type I CRISPR immunity.
They are nucleoprotein assemblies of crRNA and Cas proteins
(To help follow the variable nomenclature used in the literature
for Cas proteins within Cascade complexes: CasA= Cse1/Cas8;
CasC=Cas7; CasD=Cas5; CasE=Cas6e.). Diversity of amino
acid sequence and gene synteny between Cascade components
prompted categorization of type I CRISPR systems into sub-types
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A–F [6], with further refinement into types A–G to accommod-
ate variants in types IA, ID and IG [18]. Common structural
features are observed in Cascades from the different CRISPR
sub-types in bacteria and archaea [9,10,19–22]. crRNA is de-
livered into Cascade as a single spacer element sequence after
truncation of crRNA transcripts by Cas5 and Cas6 nucleases
[10,19,20,23–28], reviewed in [29,30]. Sulfolobus solfataricus
[19] and Thermoproteus tenax [21] Cascades (both type IA) and
Escherichia coli (type IE) [10] use multiple copies of Cas7 protein
to form a backbone filament with crRNA, functionally analog-
ous to the Csy3-crRNA backbone of Pseudomonas aeruginosa
Cascade (Type IF) [20]. Another variation of Cascade subunit
type with common function is observed in type IC systems that
use Csd2 to form Cas7-like crRNA filaments [31]. Interference
is established by Cascade base pairing crRNA with protospacer
(invader) DNA through ‘seeding’ [20,32–35] and further into
an R-loop [9], reviewed in [36] that promotes nucleolytic de-
gradation of invader DNA probably by interaction of Cascade
with Cas3 helicase-nuclease. Recent atomic structures of E. coli
Cascade complex have provided detailed insight into the arrange-
ment of protein subunits relative to one another and to crRNA
to provide a mechanism for interference in type IE CRISPR
[37–39].
Cascade can identify invader DNA by interaction with PAM
(protospacer adjacent motif) sequences. PAMs are short (2–5 nt)
sequences located on invader DNA upstream of the protospacer
that trigger Cascade–Cas3 interference [40]. A mechanism for
Cascade–PAM recognition described in E. coli involves a CasA
‘large subunit’ contacting target DNA via its ‘L1 loop’ [41,42],
as part of multiple interactions with Cas5 [37–39]. CasA is the
‘signature’ protein of type IE CRISPR systems, essential for Cas-
cade function [6]. Atomic resolution structures of Cascade [37–
39] show CasA interlocking with CasD, contributing to binding
of the crRNA 5′-handle. CasA also contacts PAM as part of
the tight association with CasD. In other type I CRISPR sys-
tems Cas8 is predicted to be functionally analogous to CasA
[18], as a ‘signature’ protein for type IA, IB and IC systems,
referred to respectively, as Cas8a2, Cas8b and Cas8c [6]. A more
recent analysis highlighted diversity of Cas8 proteins leading
to their renaming as Cas8, Cas8′ and Cas8′ ′ proteins and cre-
ating new type-I CRISPR variants based on Cas8 protein se-
quences and positioning of cas8 genes relative to other cas genes
[18]. An important role for Cas8 in interference was previously
demonstrated in the euryarchaeon Haloferax volcanii (Hvo) [43].
Here we report genetic and biochemical analyses of Cas8 homo-
logues from Hvo and Methanothermobacter thermautotrophicus
(Mth).
EXPERIMENTAL
Cultivation of Haloferax volcanii strains
H. volcanii strains H119 (!leuB, !pyrE2, !trpA) [44] and
!cas8 [22] were grown aerobically at 45 ◦C in Hv-YPC medium
[45]. H. volcanii strains!cas8 containing plasmids with mutated
cas8 genes were cultivated in Hv-Ca medium supplemented with
0.25 mM tryptophan (Trp). E. coli strains DH5α (Invitrogen) and
GM121 were grown aerobically at 37 ◦C in 2YT medium [46].
Transformation of H. volcanii and generation of
strain !cas8
For transformation of H. volcanii, plasmids were passaged
through methylase deficient E. coli GM121 cells and introduced
into H. volcanii by the PEG method [44]. Transformants were
plated on selective media. Gene deletion in H. volcanii was per-
formed as described previously [47]. Briefly, an integrative plas-
mid carrying flanking regions of the gene to be deleted and the
pyrE2 gene as an auxotrophic marker, was incorporated into the
genome by homologous recombination. Removal of this plasmid
was forced by supplementing the media using 5-fluoroorotic acid
(5-FOA, final concentration 50 µg/ml) that is converted to toxic
5-fluorouracil by orotate phosphoribosyltransferase encoded by
pyrE2 gene. Positive clones were selected by colony PCR and
gene deletion was subsequently confirmed by Southern blot hy-
bridization. Using this method cas8 was deleted resulting in strain
!cas8.
Plasmids for Haloferax volcanii
Primers and plasmids are detailed in Supplementary Informa-
tion. For generation of the integrative plasmid for cas8 dele-
tion, a cas8 fragment with up- and downstream flanking regions
(546 and 501 bp respectively) was amplified from genomic DNA
by PCR using the oligonucleotides Csh1KOup, Csh1KOdo and
Phusion DNA polymerase (Biozym). This fragment was ligated
in pTA131 digested with EcoRV. With this plasmid, an inverse
PCR was performed using the oligonucleotides IPCsh1KOup and
IPCsh1KOdo, followed by ligation of the PCR product to obtain
the integrative plasmid pTA131-cas8updo with cas8 flanking re-
gions only [48].
For complementation of cas8, pTA927-N-FLAG-cas6 [22]
was digested with HindIII and BamHI to remove cas6 and
to subsequently insert the cas8 gene. The insert was gener-
ated by a PCR on genomic DNA with oligonucleotides 5-
HindIII-cas8 and 3-cas8-NcoI-BamHI and subsequent diges-
tion of the PCR product with HindIII and BamHI. Mutations
were introduced into the cas8 gene using the QuikChange®
II-Site Directed Mutagenesis Kit (Agilent Technologies). Both
pTA927-N-FLAG-cas8 and pTA927-cas8-mutX were used for
complementation of deletion strain !cas8. For interference
tests, the four PAM sequences that have been identified for
H. volcanii TAA (PAM25), TAT (PAM26), TAG (PAM27) and
CAC (PAM54) [43] were subcloned in pTA352 [49] together
with sequence of spacer 1 from locus P1. Therefore, pTA409-
PAM25, pTA409-PAM26, pTA409-PAM27 and pTA409-PAM54
as well as pTA352 (without any insert) were digested each
with XhoI and BamHI according to previous studies [35] and
the PAM-spacer fragments were ligated each with pTA352 to
obtain pTA352-PAM25, pTA352-PAM26, pTA352-PAM27 and
pTA352-PAM54.
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Northern blot analysis of crRNA formation in
Haloferax volcanii
From H. volcanii cultures grown to exponential growth phase,
total RNA was isolated using TRIzol® Reagent (Life Techno-
logies) and remaining DNA was digested with RQ1 RNase-
Free DNase (Promega). Ten micrograms RNA was separated
on 8 % urea-polyacrylamide gels and transferred to a nylon
membrane (Hybond-N+ , GE Healthcare). For detection of
crRNA, the oligonucleotide probes against spacer 1 from locus
P1 and 5S RNA (control) were labelled radioactively using
γ -32P-ATP and T4 polynucleotide kinase (Thermo Scientific).
Signals were detected with a radiosensitive photofilm (GE
Healthcare).
Interference tests in Haloferax volcanii
A plasmid based invader assay [43] was performed to test
functionality of !cas8 x pTA927-N-FLAG-cas8 and !cas8
x pTA927-cas8-mutX in the interference reaction. Plasmid
invaders pTA352-PAM3 [43], pTA352-PAM9 [43], pTA352-
PAM25 (present study), pTA352-PAM26 (present study),
pTA352-PAM27 (present study) and pTA352-PAM54 (present
study) were used and the vector pTA352 (without any in-
sert) served as control. Transformants were plated on Hv-
Min+Trp medium without leucine and uracil. Interfer-
ence tests were performed at least three times to obtain
statistically relevant data and activity in interference was
defined for minimum 100-fold reduction in transformation
rate.
Co-purification of Cas proteins with N-FLAG-Cas7
and identification by MS
H119 was transformed with pTA927-N-FLAG-cas7 and cells
grown to a D650 of 0.6 in medium containing 0.25 mM Trp to
induce protein expression. To further induce protein expression
additional Trp was added to a final concentration of 3 mM. The
culture was incubated for further 3 h, cells were pelleted and
washed once with salt-enriched PBS buffer [2.5 M NaCl, 150 mM
MgCl2, 1× PBS (137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4,
2 mM K2HPO4, pH 7.4)]. Cells were resuspended in lysis buf-
fer [100 mM Tris/HCl, pH 7.5, 10 mM EDTA, 10 mM MgCl2,
1 mM CaCl2, 8 units/µl DNase RQ1 (Promega), 13 µl/ml pro-
tease inhibitor cocktail (Sigma)], incubated for 30 min at 4 ◦C
and subsequently lysed by sonication. Cell lysate clarified by ul-
tracentrifugation (15 min at 100,000 g) and 0.03 volume of 5 M
NaCl was added to the resulting supernatant. For subsequent
FLAG-affinity purification, the supernatant was incubated over
night at 4 ◦C with anti-FLAG M2 affinity gel (Sigma) equilibrated
with precooled washing buffer (0.2 M Tris/HCl, pH 7.4, 0.5 M
NaCl). After washing, FLAG-tagged Cas7 was eluted by adding
3× FLAG peptide (150 ng/µl in washing buffer; Sigma). Proteins
of the elution fraction were separated by SDS/PAGE (8 % poly-
acrylamide) which was subsequently stained with Coomassie.
The proteins were in-gel digested with trypsin as described in
[50]. Peptides extracted from the in-gel digestion were analysed
by LC–MS/MS on an Orbitrap XL instrument (Thermo Fischer
Scientific) under standard conditions. The fragment spectra ob-
tained for peptides were searched against H. volcanii database
(www.halolex.mpg.de) [51] using MASCOT as a search engine.
Peptides with the peptide score lower than 20 were considered
unspecific.
Methanothermobacter Cas8′ cloning, gene
expression and protein purification
DNA primer sequences for cloning and mutagenesis are listed
in Supplementary Material. Cas8′ (ORF Mth 1090) was ampli-
fied by PCR from M. thermautotrophicus !H genomic DNA.
The gene fragment cloned into pET14b facilitated expression of
N-terminal hexahistidine-tagged Mth Cas8′ (His6–Cas8′). Site-
directed mutagenesis of Cas8′ was based on the Quick-change
protocol, with mutations verified by DNA sequencing. His6–
Cas8′ protein was expressed in Escherichia coli strain BL21
Codon Plus, at 37 ◦C with expression induced by IPTG (0.5 mM)
at D600 0.6 for 2–4 h at 30 ◦C. Harvested cells were resuspen-
ded in buffer B (20 mM Tris/HCl, pH 8.0, 500 mM NaCl, 5 mM
imidazole) containing PMSF (0.1 mM) and freeze-thawed prior
to lysis by sonication, followed by centrifugation at 39 000 g for
20 min. His6–Cas8′ was purified on an AKTA–FPLC with each
step followed by SDS/PAGE. Soluble proteins were loaded on to
a 5 ml of His Trap FF column charged with nickel chloride and
equilibrated in buffer B. His6–Cas8′ eluted into fractions within
a gradient of 5 – 500 mM imidazole in buffer B were pooled
and loaded on to a HI Load Superdex 200 26/60 column equilib-
rated in buffer C (20 mM Tris/HCl, pH 8.0, 150 mM NaCl, 1 mM
DTT and 0.1mM PMSF) followed by elution in the same buffer
in one column volume. His6–Cas8′ fractions were pooled and
loaded on to 5 ml of heparin HP column equilibrated in buffer
C. His6–Cas8′ eluted in a gradient of 150–1500 mM NaCl and
fractions containing His6–Cas8′ were pooled and dialysed into
buffer D [20 mM Tris/HCl, pH 8.0, 500 mM KoAc, 1 mM DTT,
0.1 mM PMSF and 40 % (w/v) glycerol] for storage in aliquots
at − 80 ◦C. Mutant Cas8′ proteins were purified using the same
methods.
Nucleic acid substrates for analysis of Cas8′ in vitro
Oligonucleotides were purchased from MWG and are listed in
Supplementary Materials. Labelling of oligonucleotides and their
annealing into substrates followed standard methods, summar-
ized briefly: oligonucleotide (300 ng) was 5′-end-labelled with
32P from γ 32P-ATP using T4 polynucleotide kinase (NEB). La-
belled oligonucleotide was purified from unincorporated γ 32P-
ATP in BioSpin6 columns (Bio-Rad) followed by annealing
of appropriate oligonucleotide mixtures in sodium citrate buf-
fer. Substrates were purified by electrophoresis through 10 %
polyacrylamide/1× Tris-Borate-EDTA (TBE) electrophoresis,
for 3 h at 120 V and then excision of the appropriate band, detec-
ted on photographic film and elution of DNA by diffusion into
Tris (10 mM)–NaCl (50 mM) buffer, pH 7.5, at 4 ◦C.
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EMSA
EMSAs mixed protein(s) with substrate in buffer HB [100 mM
Tris/HCl, pH 7.5, 10 mM DTT, 500 µg/ml BSA and 30 % (v/v)
glycerol], typically incubated at 44.8 ◦C for 10 min. Reactions
were then mixed by pipetting and loaded directly into wells of a
gel comprising 7 % polyacrylamide in 1× TBE buffer. Protein–
nucleic acid complexes were separated by electrophoresis at
105 V for approximately 170 min in 1× TBE running buffer and
detected by gel drying and phosphorimaging. Protein–nucleic
acid complex formation was quantified compared with a no-
protein control, using AIDA software to calculate the percentage
of substrate bound and plotting in Prism to determine binding
affinity expressed as KD.
Nuclease assays
His6–Cas8′ proteins were mixed with substrates (2 nM) in HB
buffer supplemented with either 10 mM MgCl2, 5 mM EDTA or
nothing and incubated at 44.8 ◦C for 10 min. Reactions were
terminated by addition of 3 µl of stop solution [2.5 % (w/v)
SDS, 200 mM EDTA and 10 mg/ml proteinase K] and loaded
into 10 % TBE non-denaturing gels or 15 % polyacrylamide/urea
denaturing gels. Gels were dried, imaged and analysed as for
EMSAs.
Protein–protein interactions
The gene encoding cas5 (ORF Mth1087) was amplified from
M. thermautotrophicus (Mth) !H genomic DNA by PCR and
the gene fragment cloned into pMal-C2x for expression of Mth
Cas5 fused at its N-terminus to E. coli maltose-binding pro-
tein (MBP–Cas5). MBP tagging of Mth Cas5 greatly improved
its solubility and stability for expression in E. coli. cas7 (ORF
Mth1088) was amplified similarly to cas5, for cloning into pCDF-
1b generating a non-tagged Cas7 protein. Co-expression of MBP-
Cas5 and Cas7 in E. coli strain BL21 Codon Plus was in broth
containing additional glucose (0.2 % w/v), protein expression
being induced by addition of IPTG (1 mM) at D600 between
0.4–0.5. Cas5–Cas7 was purified as a complex through mul-
tiple steps on an AKTA–FPLC, followed using SDS/PAGE.
Clarified soluble proteins were loaded into a column contain-
ing 5 ml of amylose sepharose resin and equilibrated in amyl-
ose column-binding buffer (ACBB; 20mM Tris/HCl, pH 8.0,
100 mM NaCl, 1 mm DTT and 0.1 mM PMSF). MBP–Cas5
and Cas7 co-eluted within a gradient of 0–5 mM maltose in
ACBB and fractions containing MBP–Cas5–Cas7 were pooled
and loaded on to 5 ml of Heparin HP column equilibrated in buf-
fer C. MBP–Cas5–Cas7 co-eluted in a gradient of 150–1500 mM
NaCl and fractions containing MBP–Cas5–Cas7 were pooled and
dialysed into buffer D [20 mM Tris/HCl, pH 8.0, 500 mM KoAc,
1 mM DTT and 40 % (w/v) glycerol] for storage in aliquots at
− 80 ◦C.
MBP–Cas5–Cas7 was used to test for physical interaction
with Cas8′. Fifty microlitres of amylose resin slurry was equi-
librated in 100 µl of wash buffer (W; 20 mM Tris/HCl, pH 8.0,
150 mM NaCl, 1 mM EDTA and 1 % Tween) and centrifuged at
700 g for 30 s, supernatant removed and washing repeated five
times. Twenty micrograms of MBP–Cas5–Cas7, His6–Cas8′ or
MBP–Cas5 and –Cas7 and His6–Cas8b′ we added to the resin
to a final volume of 500 µl and end-to-end mixed for 2–4 h at
4 ◦C. Resin was pelleted as before and washed three times as pre-
viously. SDS/PAGE disruption buffer was added to resin pellet
and boiled. First wash and pellet analysed via SDS/PAGE. Two
identically loaded SDS/PAGE gels were used for electroblot-
ting on to PVDF and western blotting to detect the presence of
MBP–Cas5 or His6–Cas8′ proteins via their affinity tags. Mem-
branes were incubated overnight at 4 ◦C in western blocking buf-
fer (WBB; 50 mM Tris/HCl, pH 7.6, 150 mM NaCl and 0.1 %
Tween, supplemented with 5% milk powder), before probing
each separately with monoclonal antibodies against MBP (NEB)
or His6 (Sigma). Washed membranes were then probed with
HRP-conjugated anti-mouse antibody (against His6) or anti-goat
antibody (against MBP) to develop using an ECL detection kit
and imaged using FujiFilm LAS300 machine.
RESULTS
Mutations in Cas8 that inactivate CRISPR
interference
Plasmid protection assays in H. volcanii (Hvo) identified multiple
PAM sequences and that disruption of cas8 abolished interfer-
ence [43]. To investigate Cas8 further, !cas8 Hvo cells were
analysed in plasmid protection assays when expressing mutant
or wild-type Cas8 from a second plasmid (Figure 1A). Single
amino acid substitutions were introduced into Hvo Cas8 based
on the alignment with Cas8 homologues from archaea and a
bacterium (summarized in Figures 1B and 1C and a full align-
ment in Supplementary Figure S1). Cas8 proteins are diverse
[18] with low overall sequence identity, but conserved amino
acids were identified to investigate Cas8 function (Figure 1C).
Mutation in Hvo Cas8 Asp230, Asn625 and Leu627 abolished in-
terference, equivalent to cells lacking cas8 (Figure 1D). Mutated
Asn232 showed reduced interference, by∼20 %, toward plasmids
with PAM 5′-TTC, but had little effect on interference toward
plasmid with PAM 5′-ACT (Figure 1D). Additional assays on
!cas8 Hvo pN232A-Cas8 using six Hvo PAMs highlighted a
PAM bias, with interference reduced when PAM 5′-TTC or 5′-
CAC was used, but with no effect of N232A on the other PAMs
(Figure 1E). These genetic assays identified regions of Cas8 that
are essential for interference and suggest that Cas8 is sensitive to
PAM sequences.
Cas8′ binding to DNA and R-loop nucleic acid
substrates
As noted in Figure 1, homologues of Hvo Cas8 are present in
other archaea and bacteria. Hvo is an extreme halophile, cre-
ating problems for analysis in native conditions of Hvo Cas8
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Figure 1 Effect on CRISPR interference of mutations in Archaeal Cas8
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binding to DNA/RNA substrates in EMSAs. Therefore, we pur-
ified the Cas8 homologue from M. thermautotrophicus (Mth)
(Supplementary Figure S2), an organism amenable for ana-
lysis of its DNA-binding proteins. Mth Cas8 is called Cas8′
[18] because it is 119 amino acids shorter than Hvo Cas8,
but it has the conserved amino acid residues required for CR-
ISPR interference by Hvo Cas8, summarized in Figures 1C–1E.
We constructed nucleic acid substrates for Cas8′ binding that
centred on duplex DNA or R-loop shown in Figure 2(A). Sub-
strates were either + or − PAM and contained a 5′-crRNA
handle known to be important for interference in type IB CR-
ISPR systems, whereas the 3′-handle is dispensable for interfer-
ence in the same systems [52]. To predict Mth PAM, we ana-
lysed 123 spacers in Mth CRISPR-1, identifying protospacers
from seven mobile genetic elements to deduce a PAM of 5′-
CCN-3′, detailed in Supplementary Results and Supplement-
ary Figure S3. CC dinucleotide PAM for Mth had been iden-
tified in a previous analysis [53], although reported as GG from
the reverse complement of the Mth genome. Therefore we in-
corporated 5′-CCC into substrates for +PAM or 5′-AAA for
−PAM.
Results of Cas8′ EMSAs are in Figures 2(B) and 2(C).
Cas8′ bound to a +PAM R-loop or duplex DNA with
highest affinity (Figure 2B respectively, Kd 5.3+− 0.7 nM
and Kd 9.1 +−0.2 nM), compared with the same substrates
−PAM (Figure 2B respectively, Kd 40.7+− 1.0 nM and Kd
18.3+− 0.8 nM). It was significant that Cas8′ bound to R-
loops, + or − PAM, as distinct in-gel protein–DNA com-
plexes, compared with in well aggregates of protein–DNA
observed for Cas8′ mixed with duplex DNA (Figure 2C).
These EMSAs suggested that Cas8′ in isolation can recognize
PAM sequence and may have structural preference for bind-
ing stably to branched DNA or R-loops compared with duplex
DNA.
Physical interaction of Cas8′ with Cas5–Cas7 and
PAM-dependent stimulation of nucleic acid binding
Cas5 and Cas7 are integral to bacterial and archaeal Cas-
cades [9,19] and are predicted to function with Cas8 during
CRISPR interference. Previous studies identified a Cas5–Cas7
complex in Hvo [22] and physical association of Cas8′ with
Cas7 during fractionation of Methanothermobacter cell bio-
mass [54]. In the present work, FLAG-tagged Cas7 was ex-
pressed in Hvo cells to detect protein interactors, identifying
Cas8 when FLAG–Cas7 affinity enriched cell extracts were
analysed by MS (Figure 3A). To test for physical interaction
of Cas8′ with Cas5–Cas7, we first co-purified Mth Cas7 with
Cas5 (Supplementary Figure S4A), the latter an N-terminal
fusion to E. coli MBP, giving soluble MBP–Cas5–Cas7 that
bound crRNA1. MBP–Cas5–Cas7 interacted physically with
Cas8′ (Figure 3B), with the same results observed either with
or without pre-incubation of Cas5–Cas7 with crRNA1. Cas8′
bound to MBP–Cas5–Cas7 pre-incubated with amylose resin
(Figure 3B, top panel, lane 8), but did not bind to control amylose
resin in BSA (Figure 3B, top panel, lane 6). MBP–Cas5–Cas7
was detected, as expected, in Figure 3(B), lane 8, but not in
lane 6 containing BSA. The reciprocal reaction (MBP–Cas5–
Cas7 to Ni2+ -NTA bound Cas8′) was not effective because
MBP–Cas5–Cas7 bound Ni2+ -NTA even when Cas8′ was ab-
sent. These assays indicated physical interaction of Cas8′ with
Cas5–Cas7, although a maximum of only 10 % of Cas8′ in-
put could be detected as bound to MBP–Cas5–Cas7 in these
conditions.
Cas8′ was tested for any influence effect on binding by
Cas5–Cas7 to duplex +− PAM in EMSAs. Cas8′ stimulated total
substrate binding when +PAM but had little effect on bind-
ing to −PAM (Figure 3C and representative gels in Supple-
mentary Figure S4B). Significantly, EMSAs mixing Cas5–Cas7
+ Cas8′ showed a novel complex that was not present when
either Cas5–Cas7 or Cas8 were alone (Figure 3D): Cas5–Cas7
at 10 nM or 100 nM formed in-well protein–DNA aggregates
with, respectively, 8 % and 67 % of substrate (labelled A, Fig-
ure 3D, lanes 1 and 2). Cas8′ alone (5 nM) bound 55 % of
the substrate in distinct complexes (labelled B in Figure 3D,
lane 3). A new complex (complex C) was defined when pre-
mixing Cas8′ (5 nM) with Cas5–Cas7 (10 or 100 nM) and 90 %–
100 % of substrate was bound (Figure 3D, lanes 4 and 5). West-
ern blotting of identical EMSA using antibodies against MBP
identified MBP–Cas5–Cas7 in complex C (Figure 3D, lanes 8
and 9), confirming that Cas5–Cas7 can form a distinct com-
plex in EMSAs that is not an aggregate but dependent on
Cas8′.
(A) Summary of H. volcanii (Hvo) plasmid protection assays. See also parts (D) and (E). Transformation efficiency was
measured for a plasmid containing PAMs into Hvo !cas8 cells complemented by pCas8+ or pCas8MUTANT to determine
their effects on interference. Efficient transformation of plasmid containing a PAM [43] and protospacer indicated loss of
interference, manifest as colony growth supported by leu and ura complementation from the plasmid. (B) Type IB CRIS-
PR-Cas systems of the euryarchaea H. volcanii (Hvo) and M. thermautotrophicus (Mth) and the bacterium Clostridium tetani
(Cte). All have conserved gene order Cas8-Cas7-Cas5-Cas3. Mth contains an additional open reading frame (mth1089)
called Cas8′ ′ leading to its classification as a CRISPR type IB variant V1-2 and renaming of Cas8b [6] to Cas8′ [18]. The
predicted amino acid sequence of Cas8′ ′ shows no significant homology to any protein in database searches. (C) Cartoon
illustrating two conserved amino acid patches in Hvo Cas8 and Mth Cas8′ homologues, which were targeted for mutagen-
esis in data presented in parts (D) and (E) and in the subsequent data Figures. A full alignment of Cas8/Cas8′/Cas8b is
given in Supplementary Figure S1. (D) Relative interference efficiencies supported by Hvo Cas8 and its mutant proteins
when measured in cells deleted for cas8 (!cas8) in the assay summarized in Figure 1(A) using two different Hvo PAMs, as
indicated. A transformation efficiency of 1.0 corresponds to no significant interference from an absence of Cas8 plasmid
(‘no Cas8 plasmid’) or from mutations D230A, N625A and L627A. (E) Interference efficiency of!cas8 Hvo cells expressing
Cas8 N232A in the presence of plasmid harbouring any one of the six Hvo PAMs, as indicated.
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Figure 2 EMSAs for binding Cas8′ to duplex and R-loop with + and −PAM
(A) Cartoon of R-loop/duplex model substrates used; sequences of DNA and RNA strands are given in supplemental data.
+PAM 5′ -CCN (CCC) or −PAM (AAA) sequences and a 5′ RNA handle were incorporated into duplex or R-loop as indicated.
For R-loop, crRNA oligonucleotide (shown in red) was synthesized with sequence complementary to a spacer from Mth
CRISPR-1. (B). Graphs comparing measurements of Cas8′ binding to duplex and R-loop substrates +− PAM, as indicated
in each panel i–iv. Asterisks denote the 32P-end labelled DNA strand. EMSAs were in triplicate for plotting as mean values
with bars for standard error. Substrate (2.0 nM) was mixed with Cas8′ at concentrations (nM): 0, 1.56, 3.125, 6.25, 12.5,
25.0, 50.0, 100, 120, 200. (C) Cas8′ gave distinct in gel complex when binding to R-loop (labelled B), compared with in
well aggregates of protein–nucleic acid (complex A) with a duplex DNA.
Cas8 amino acid residues that are essential for
interference in vivo are also essential for a Cas8′
nuclease activity in vitro
Mutant Mth Cas8′ proteins D151G, N153A and N536A were
purified (Supplementary Figure S2), corresponding to mutations
in Hvo Cas8 that had reduced or abolished interference activ-
ity in plasmid protection assays (Asp230, Asn232 and Asn625
Table 1A). Cas8′ mutant proteins were proficient in binding
to R-loop +PAM (Supplementary Figure S5) and other sub-
strates (result not shown) and interacted with MBP–Cas5-Cas7
(Supplementary Figure S6). We investigated N153A substrate
binding in more detail because the corresponding Hvo muta-
tion (Asn232) caused reduced interference to PAMs 5′-CAC or
-TTC (Table 1B). Duplex and R-loop substrates containing PAM
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Figure 3 Interaction of Cas8 and Cas8′ with Cas5–Cas7
(A) Coomassie stained SDS/PAGE profile of co-purifying proteins with Flag-Tagged Cas7 expressed in Haloferax cells.
Cas8 was detected by MS. (B) Reconstitution of physical interaction between purified Methanothermobacter Cas8′ (20 µg)
with purified complex of affinity tagged Methanothermobacter Cas5–Cas7 (20 µg). Upper panel shows western blot using
anti-(His)6 antibody to detect (His)6Cas8′ and the lower panel used anti-MBP antibody to detect MBP in MBP–Cas5–Cas7.
‘Input’ is a duplicate loading of total amount of used Cas8′ (upper panel) or Cas5–Cas7 (lower panel). Cas8′ was detected
in the elution (E) after binding to amylose –MBP–Cas5–Cas7 (lane 8) but did not bind to amylose pre-bound with BSA (lane
6). (C) Measurements of duplex DNA binding +−PAM by Methanothermobacter Cas5–Cas7 either with or without Cas8′, as
labelled. Data values for total DNA binding were calculated for each concentration of Cas5–Cas7 (4, 8, 15 nM) +−Cas8′
(5 nM). (D) Corresponding EMSA and western blots for detection of Cas5–Cas7 in a Cas8′ dependent in-gel complex.
Lanes 1–5 (left panel) show phosphorimaged EMSA complexes arising from reactions binding of Cas5–Cas7 (complex
A) or Cas8′ (B complexes). A new complex C was observed when Cas5–Cas7 and Cas8′ are present. Western blotting
detected Cas5–Cas7 in complex C (lanes 8 and 9), as well as complex A (lanes 6, 8 and 9).
5′-CCC were not bound by N153A appreciably better than sub-
strates −PAM in EMSAs (Figure 4A), contrasting with the bind-
ing behaviour of wild-type Cas8′ (Figure 2). It is possible that
this observation might account for subtly reduced interference,
discussed later.
To test for Cas8′ catalytic activity correlating to lack of inter-
ference from the aspartic acid/asparagine mutants we re-visited
previous work that had identified Mth Cas8′ nuclease activity tar-
geting ssDNA flaps [54]. We now compared this DNase activity
to equivalent RNase activity. Cas8′ was much more efficient as a
nuclease, measured as a function of time, on an ssRNA flap of the
same sequence as ssDNA (Figure 4Bi). In these reactions, RNA
was present in a RNA–DNA hybrid, but RNA nuclease activity
was not detected in RNA–RNA duplex, even though Cas8′
binding to DNA–DNA, RNA–DNA and RNA–RNA substrates
was similar (Supplementary Figure S7). Cas8′ nuclease activity
was detected on RNA with 3′- and 5′-ends (Figure 4Aii), but
only on the strand with ssRNA overhang. Cas8′ D151G and
N536A had negligible RNase activity (Figure 4C, with further
examples of nuclease assay gels in Supplementary Figure S8A),
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Figure 4 Cas8′ substrate binding and nuclease activities
(A) Binding of N153A Cas8′ to substrates +−PAM as indicated in panels
i–iv, for comparison with wild-type Cas8′ data in Figure 2(B). Asterisks
denote the 32P-end labelled DNA strand. EMSAs were in triplicate for
plotting as mean values with bars for standard error. Substrate (2 nM)
was mixed with Cas8′ N153A at concentrations of (nM); 0, 1.56, 3.125,
6.25, 12.5, 25.0, 50.0, 100, 150 and 200 for panels i and ii; 0, 1.56,
but binding was intact (Supplementary Figure S8B). N153A had
intermediate nuclease activity (Figure 4C). The catalytic activity
of Cas8′ and inactivating mutations in conserved residues that
are required for interference in Hvo, is evidence that Cas8′ is an
RNA nuclease in cells, discussed more below.
DISCUSSION
Cas8 proteins are candidates for guiding Cascade to invader DNA
in some type I CRISPR systems [18,21]. Mutation of Cas8 had
been implicated in loss of interference in Haloferax (Hvo) [43]
and we investigated this using genetic analysis of Hvo Cas8 in
CRISPR interference and nucleic acid binding and processing
by Cas8′ from Methanothermobacter (Mth). We propose that
Cas8/Cas8′ is part of Cascade, contributing to PAM and structure
specific nucleic acid binding, influencing interaction of Cas5–
Cas7 with nucleic acids. An interesting ssRNA nuclease activity
of Cas8′ was detected in vitro, requiring conserved amino acids
that are essential for interference in vivo.
Three lines of evidence indicated nucleic acid binding and
PAM sensing by Cas8′, in isolation and when mixed with Cas5–
Cas7. Firstly, isolated Cas8′ formed distinct complexes with R-
loop substrates in EMSAs and predicted PAM 5′-CCN stimu-
lated its binding to duplex and R-loop substrates (Figure 2).
Second, the subtle PAM induced behaviour of Cas8 or Cas8′
mutated in respectively, Asn232 (Tables 1A and 1B) or Asn153
(Figure 4A) supports interaction with PAM either alone or when
bound with Cas5–Cas7 in Cascade, an interaction that is per-
turbed by the asparagine mutation. Third, we observed enhanced
substrate binding from Cas8′–Cas5–Cas7 +PAM, compared
with either Cas5–Cas7 or Cas8′ alone, which was not observed
when −PAM (Figure 3). Cas8′ in these assays converted Cas5–
Cas7 protein aggregates into a distinct binding complex suggest-
ing that Cas8′ modulates how Cas5–Cas7 can precisely assemble
on the substrate, thereby controlling its aggregation. Based on
E. coli Cascade structures detailing precise positioning for CasA
relative to CasD (Cas5) [37–39], it is likely that interaction of
Cas8 with Cas5–Cas7 is important for PAM sensing and for the
choreography of Cascade binding to nucleic acids that leads to
stable R-loop formation.
Mutation of Hvo Asp230 and Asn625 abolished Cas8 interfer-
ence (Table 1A) and mutation of the corresponding residues in
3.125, 6.25, 12.5, 25.0, 50.0, 100, 120 and 200 for panel iii and
0, 6.25, 12.5, 20.0, 40.0, 80.0 and 160 nM in panel iv. (B) Graphs
comparing Cas8′ (100 nM) nuclease activity as a function of time on;
panel i, comparing DNase to RNase activity on 3′ ssDNA or ssRNA flaps
(1 nM of each), panel ii, comparing RNase activity on 3′ or 5′ ssRNA
flaps (1 nM of each). In each case the strand labelled was that with the
single stranded region and assays were analysed on denaturing gels
in triplicate for plotting as mean values with bars for standard error.
(C) Comparative RNase activity of Cas8′ and mutants on 5′ -ssRNA flap
(1 nM) containing protein at 0, 50, 100, 200, 400 and 600 nM. In each
panel the data points are means of assays in duplicate showing stand-
ard error and representative gels for wild-type Cas8′ and a catalytically
inactive Cas8′ (D151G) are shown below the graph.
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Mth Cas8′, Asp151 and Asn536, abolished ssRNA nuclease activ-
ity (Figure 4). Cas8′ degraded ssRNA with either 3′- or 5′-ends.
However, we were unable to detect RNase activity in vitro from
Hvo Cas8, despite using a wide range of high and low salt assay
conditions, possibly because of instability of the purified protein
that appeared during storage. Therefore we cannot conclude that
abolished nuclease activity of Cas8′ D151G and N536A mutants
explains the loss of genetic interference by Hvo Cas8 D230A
and N625A mutants, but the correlation is interesting. Northern
blotting for crRNA in Hvo !cas8 cells showed that Cas8 is not
needed for processing crRNA into pre-crRNA or crRNA in cells
(Supplementary Figure S9). Also, Hvo cells do contain a nuclease
that removes nts from the 3′-end of crRNA after processing from
pre-crRNA but this RNase function is not altered if cells lack
Cas8 (Anita Marchfelder, personal communication). 5′-crRNA
handles are essential for interference in Hvo cells and are there-
fore not processed after crRNA formation [52]. Therefore the role
of Cas8 RNase activity, if any, in Cascade-mediated CRISPR in-
terference is undetermined. We cannot exclude the possibility
that Cas8 RNase activity may be needed for some other aspect of
RNA metabolism and processing in these organisms that has an
indirectly important role for some type I CRISPR systems.
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